Korean Biotech Roundup: GNT Set For First Direct Korean Biopharma IPO On Nasdaq

Others Sign Big Deals With Multinationals

 
• By Jung Won Shin
  
Nasdaq
ABL Bio, Other Bioventures Dominate Large Global Deals So Far (Shutterstock)

More from South Korea

More from Business